Optimizing In-House Testing: Enhancing Efficiency for Timely Results and Treatment Decisions

Author(s):

Panelists discuss how in-house testing significantly reduces turnaround times by eliminating send-out delays and courier dependencies. This enables immediate sample processing, allowing for faster results delivery and prompt clinical decision-making. Health care facilities can optimize workflows through automated systems, clear communication protocols, and standardized testing procedures, minimizing bottlenecks between departments and facilitating quicker diagnosis and treatment initiation.

EP: 1.Key Considerations When Ordering Biomarker Testing

EP: 2.The Importance of Broad Biomarker Testing: Uncovering Actionable Targets Across Tumor Types

EP: 3.When to Choose Narrow Panel Testing Over Comprehensive Testing in Biomarker Analysis

EP: 4.Centralized vs Decentralized Biomarker Testing: Workflow, Control, and Collaboration Insights

EP: 5.In-House Comprehensive Genomic Profiling: Expert Insight Into Balancing Benefits and Challenges

EP: 6.Implementing In-House Biomarker Testing: Rationale and Key Considerations

Now Viewing

EP: 7.Optimizing In-House Testing: Enhancing Efficiency for Timely Results and Treatment Decisions

EP: 8.Enhancing Multidisciplinary Coordination and Treatment Planning Through In-House Testing

EP: 9.Impact of In-House Testing on Improved Cancer Care: Timely Decisions and Enhanced Treatment Accuracy

Video series above is prompted by the following:

How does in-house testing ease challenges with test ordering and delivery of timely results?
How has your institution streamlined workflows to address bottlenecks and ensure faster diagnosis and treatment decisions?